Published in Hum Vaccin Immunother on November 01, 2014
Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. J Infect Dis (2016) 1.02
Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus. Hum Vaccin Immunother (2015) 0.83
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis (2011) 14.93
Field evaluation of vaccine efficacy. Bull World Health Organ (1985) 4.95
Influenza vaccine: the challenge of antigenic drift. Vaccine (2007) 4.23
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol (2007) 3.33
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis (2009) 3.26
Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis (2012) 2.91
Influenza vaccines for the future. N Engl J Med (2010) 2.54
Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One (2014) 1.90
Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill (2013) 1.77
Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States, February 2013. MMWR Morb Mortal Wkly Rep (2013) 1.77
Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine (2010) 1.57
Vaccination and antigenic drift in influenza. Vaccine (2008) 1.56
The vaccination coverage required to establish herd immunity against influenza viruses. Prev Med (2012) 1.54
Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Euro Surveill (2013) 1.33
Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One (2009) 1.32
Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill (2013) 1.22
Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine (2010) 1.16
Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants. J Infect Dis (2012) 1.14
Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis (2013) 1.13
Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy. Vaccine (2009) 1.04
Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13. Euro Surveill (2013) 0.96
Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine (2007) 0.95
Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. Euro Surveill (2014) 0.93
Distinguishing vaccine efficacy and effectiveness. Vaccine (2012) 0.91
Understanding suboptimal influenza vaccine effectiveness within the agent, host, and environment paradigm. Clin Infect Dis (2013) 0.86
Overview of vaccine field studies: types of effects and designs. J Biopharm Stat (2006) 0.80
Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study. Euro Surveill (2014) 0.80
Differences in sentinel influenza confirmed incidence rates and clinical presentation of influenza virus: 2008-09 seasonal vs 2009-10 pandemic influenza. Hum Vaccin (2011) 0.79
Influenza: current evidence and informed predictions. Expert Rev Vaccines (2004) 0.77
Influenza sentinel surveillance network: a public health-primary care collaborative action to assess influenza A(H1N1)pmd09 in Catalonia, Spain. Hum Vaccin Immunother (2013) 0.77
Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study. Thorax (2013) 3.05
Non-ATP competitive glycogen synthase kinase 3beta (GSK-3beta) inhibitors: study of structural requirements for thiadiazolidinone derivatives. Bioorg Med Chem (2007) 1.98
[Meningococcal disease in Catalonia, Spain (1990-1997)]. Med Clin (Barc) (2004) 1.89
Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule. Clin Infect Dis (2008) 1.85
Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial. Arch Intern Med (2007) 1.78
[Priorities in health promotion according to primary care health professionals: a Delphi study]. Aten Primaria (2007) 1.39
[Severe acute respiratory syndrome]. Med Clin (Barc) (2003) 1.39
Construction of simplified models to simulate estrogenic disruptions by esters of 4-hydroxy benzoic acid (parabens). Biophys Chem (2008) 1.39
Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. J Biol Chem (2005) 1.34
Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. J Epidemiol Community Health (2007) 1.28
Influenza vaccine coverage, influenza-associated morbidity and all-cause mortality in Catalonia (Spain). Vaccine (2011) 1.16
A brief measure of high nicotine dependence for busy clinicians and large epidemiological surveys. Aust N Z J Psychiatry (2005) 1.14
Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis (2013) 1.13
Human West Nile virus infection, Catalonia, Spain. Emerg Infect Dis (2006) 1.11
Predictors of "quality of work" and "poor health" among primary health-care personnel in Catalonia: evidence based on cross-sectional, retrospective and longitudinal design. Int J Health Care Qual Assur (2008) 1.09
Assessment of exposure to secondhand smoke by questionnaire and salivary cotinine in the general population of Barcelona, Spain (2004-2005). Prev Med (2009) 1.08
Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease. J Nat Prod (2007) 1.05
Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease. J Med Chem (2005) 1.05
Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain. Clin Vaccine Immunol (2006) 1.03
Foodborne norovirus outbreak: the role of an asymptomatic food handler. BMC Infect Dis (2010) 1.01
Sequential evolution of genotype GII.4 norovirus variants causing gastroenteritis outbreaks from 2001 to 2006 in Eastern Spain. J Med Virol (2008) 0.98
Prevalence of Parkinson's disease in Cantalejo, Spain: a door-to-door survey. Mov Disord (2002) 0.98
Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization. Prev Med (2012) 0.98
Maternal age at birth and childhood type 1 diabetes: a pooled analysis of 30 observational studies. Diabetes (2009) 0.97
Influenza C virus surveillance during the first influenza A (H1N1) 2009 pandemic wave in Catalonia, Spain. Diagn Microbiol Infect Dis (2011) 0.94
Outbreak of nosocomial hepatitis C virus infection resolved by genetic analysis of HCV RNA. J Clin Microbiol (2002) 0.94
Cephalosporin-resistant Escherichia coli among summer camp attendees with salmonellosis. Emerg Infect Dis (2003) 0.93
The extension of smoke-free areas and acute myocardial infarction mortality: before and after study. BMJ Open (2011) 0.92
Strongyloides stercoralis, the hidden worm. Epidemiological and clinical characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012. Trans R Soc Trop Med Hyg (2013) 0.92
Epidemiology of pertussis in a country with high vaccination coverage. Vaccine (2011) 0.92
β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS. Environ Toxicol Pharmacol (2013) 0.92
Clinical presentation of invasive pneumococcal disease in Spain in the era of heptavalent conjugate vaccine. Pediatr Infect Dis J (2012) 0.91
Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds. J Med Chem (2011) 0.90
D225G mutation in the hemagglutinin protein found in 3 severe cases of 2009 pandemic influenza A (H1N1) in Spain. Diagn Microbiol Infect Dis (2010) 0.90
[Estimating cardiovascular risk in Spain using different algorithms]. Rev Esp Cardiol (2007) 0.90
Sociodemographic factors and clinical conditions associated to hospitalization in influenza A (H1N1) 2009 virus infected patients in Spain, 2009-2010. PLoS One (2012) 0.89
[Reproductive and perinatal health indicators in immigrant and Spanish-born women in Catalonia and Valencia (2005-2006)]. Gac Sanit (2009) 0.89
Recent immigration and adverse pregnancy outcomes in an urban setting in Spain. Matern Child Health J (2011) 0.89
Parental knowledge of paediatric vaccination. BMC Public Health (2009) 0.89
Is the vaccination coverage established enough to control pertussis, or it is a re-emerging disease? Vaccine (2009) 0.88
Carotenoids can act as antioxidants by oxidizing the superoxide radical anion. Phys Chem Chem Phys (2009) 0.88
The role of gender in a smoking cessation intervention: a cluster randomized clinical trial. BMC Public Health (2011) 0.88
Time-series analysis of meningococcal disease in Catalonia. Ann Epidemiol (2007) 0.88
Trends in physical activity status in Catalonia, Spain (1992-2003). Public Health Nutr (2007) 0.88
Prevalence of hepatitis E virus infection in children in the northeast of Spain. Clin Vaccine Immunol (2008) 0.87
[Outbreak of gastroenteritis caused by Campylobacter jejuni transmitted through drinking water]. Med Clin (Barc) (2002) 0.87
Caesarean section rates in immigrant and native women in Spain: the importance of geographical origin and type of hospital for delivery. Eur J Public Health (2010) 0.87
Trends in influenza vaccine coverage among primary healthcare workers in Spain, 2008-2011. Prev Med (2013) 0.87
Synthesis, structural analysis, and biological evaluation of thioxoquinazoline derivatives as phosphodiesterase 7 inhibitors. ChemMedChem (2009) 0.87
Health-related quality of life in carers of patients with dementia. Fam Pract (2004) 0.87
Trends in dietary habits and food consumption in Catalonia, Spain (1992-2003). Public Health Nutr (2007) 0.86
Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties. ChemMedChem (2009) 0.86
Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the α synuclein gene. Parkinsonism Relat Disord (2012) 0.85
Carbohydrates and their free radical scavenging capability: a theoretical study. J Phys Chem B (2012) 0.85
Epidemiology of two large measles virus outbreaks in Catalonia: what a difference the month of administration of the first dose of vaccine makes. Hum Vaccin Immunother (2013) 0.85
Aetiology and epidemiology of viral gastroenteritis outbreaks in Catalonia (Spain) in 2004-2005. J Clin Virol (2008) 0.85
Neuroprotective effect of the new thiadiazolidinone NP00111 against oxygen-glucose deprivation in rat hippocampal slices: implication of ERK1/2 and PPARgamma receptors. Exp Neurol (2008) 0.85
Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain). Med Microbiol Immunol (2007) 0.84
[Descriptive study of hepatitis outbreaks occurring in Catalonia (1999-2003)]. Enferm Infecc Microbiol Clin (2006) 0.84
Influence of socioeconomic status on community-acquired pneumonia outcomes in elderly patients requiring hospitalization: a multicenter observational study. BMC Public Health (2010) 0.83
Construction of the birth weight by gestational age population reference curves of Catalonia (Spain): Methods and development. Gac Sanit (2009) 0.83
[Surveillance of the pandemic influenza (H1N1) 2009 in Catalonia: results and implications]. Rev Esp Salud Publica (2011) 0.83
The longest polyene. Org Lett (2012) 0.83
Risk factors for invasive pneumococcal disease in a community with a high proportion of non vaccine serotypes. Vaccine (2012) 0.83
Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model. Eur J Med Chem (2011) 0.83
Theoretical study of the novel sandwich compound [Au3Cl3Tr 2]2+. J Mol Model (2008) 0.83
Epidemiology of vaccine-preventable invasive diseases in Catalonia in the era of conjugate vaccines. Hum Vaccin Immunother (2013) 0.82
Health-related quality-of-life of care-givers as a predictor of nursing-home placement of patients with dementia. Alzheimer Dis Assoc Disord (2005) 0.82
A statistical model to estimate the impact of a hepatitis A vaccination programme. Vaccine (2008) 0.82
[Use of services and costs in patients with influenza (H1N1) 2009 in Spain: background and research protocol]. Rev Esp Salud Publica (2011) 0.82
[Changes in smoking prevalence among adolescents in Spain]. Aten Primaria (2011) 0.82
Social factors related to the clinical severity of influenza cases in Spain during the A (H1N1) 2009 virus pandemic. BMC Public Health (2013) 0.82
Prevalence of antibody to Bordetella pertussis in neonates and prevalence of recent pertussis infection in pregnant women in Catalonia (Spain) in 2003 and 2013. Pediatr Infect Dis J (2014) 0.82
Infection with human herpesvirus 6 after kidney-pancreas transplant. Am J Transplant (2004) 0.82
Theoretical study on the series of [Au(3)Cl (3)M (2)] complexes, with M = Li, Na, K, Rb, Cs. J Mol Model (2009) 0.81
Dual binding site acetylcholinesterase inhibitors: potential new disease-modifying agents for AD. J Mol Neurosci (2006) 0.81
Thienylhalomethylketones: Irreversible glycogen synthase kinase 3 inhibitors as useful pharmacological tools. Bioorg Med Chem (2009) 0.81
Hepatitis A outbreaks in the vaccination era in Catalonia, Spain. Hum Vaccin (2011) 0.81
Thienyl and phenyl alpha-halomethyl ketones: new inhibitors of glycogen synthase kinase (GSK-3beta) from a library of compound searching. J Med Chem (2003) 0.81
Cis carotenoids: colorful molecules and free radical quenchers. J Phys Chem B (2013) 0.81
Prevalence of measles antibodies among health care workers in Catalonia (Spain) in the elimination era. BMC Infect Dis (2013) 0.81
[The evaluation of effectiveness of scholastic programs in the prevention of consumption of tobacco, alcohol and cannabis: what do meta-analyses tell us?]. Rev Esp Salud Publica (2002) 0.81
Theoretical study of cytosine-Al, cytosine-Cu and cytosine-Ag (neutral, anionic and cationic). J Phys Chem A (2008) 0.80
Cost-effectiveness of rifampin for 4 months and isoniazid for 6 months in the treatment of tuberculosis infection. Respir Med (2013) 0.80
The metal cation chelating capacity of astaxanthin. Does this have any influence on antiradical activity? Molecules (2012) 0.80
CODES, a novel procedure for ligand-based virtual screening: PDE7 inhibitors as an application example. Eur J Med Chem (2007) 0.80
Prevalence of human metapneumovirus among hospitalized children younger than 1 year in Catalonia, Spain. J Med Virol (2008) 0.80
[The viral gastroenteritis: a public health problem]. Rev Esp Salud Publica (2010) 0.80
Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: influence of neuraminidase inhibitors. J Antimicrob Chemother (2012) 0.80
Are risk factors associated with invasive pneumococcal disease according to different serotypes? Hum Vaccin Immunother (2013) 0.80
Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program. Hum Vaccin Immunother (2014) 0.80
Ca, Cd, Zn, and their ions interacting with Cytosine: a theoretical study. J Phys Chem A (2007) 0.80
Gender differences in sexual risk behaviour among adolescents in Catalonia, Spain. Gac Sanit (2011) 0.79
Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis mice. ACS Chem Neurosci (2012) 0.79
[Norovirus outbreaks in hospitals and nursing homes in Catalonia, Spain]. Rev Esp Salud Publica (2010) 0.79
Effectiveness of measles vaccination for control of exposed children. Pediatr Infect Dis J (2011) 0.79
Validity of self-reported pneumococcal vaccination status in the elderly in Spain. Vaccine (2009) 0.79